Should CVS Health Break Up?
CVS Health is reportedly exploring a breakup. But some experts aren’t sure if this is a good idea. The post Should CVS Health Break Up? appeared first on MedCity News.
Read More
Try This When Your Doctor Says ‘Yes’ to a Preventive Test but Insurance Says ‘No’
“My son was diagnosed with congenital CMV, a virus that can cause hearing loss. As part of this diagnosis, he will be required to have routine hearing tests every few months until he is 10 years old. I reached out to you because I wanted to know why my son’s hearing tests weren’t covered by…
Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development
Deploying a robust continuous improvement methodology is especially beneficial in the earliest phases of drug development. It can help ensure the delivery of high-quality, reliable, timely bioanalytical and clinical data to make informed decisions about either moving on to the next drug development milestone or pivoting to another strategy. The post Continuous Process Improvement: The…
Prediction: The Caregiving Question Harris and Trump Will Have to Address in the Presidential Debate
What should we expect in Tuesday’s debate? If past performance is any indication, probably a lot of hemming and hawing — but we should demand concrete plans for paid family leave, Social Security credits for caregivers, and strategies to leverage technology in support of care work. The post Prediction: The Caregiving Question Harris and Trump…
What Forced CMS to Terminate the MA Value-Based Insurance Design Model?
Calling the costs ‘unprecedented’ in CMS Innovation Center models, the VBID model cost CMS $2.3 billion in CY 2021 and $2.2 billion in CY 2022
The Trump Administration’s Foreign Aid Freeze and Global Health: The Biggest Gaps Left on the Donor Landscape
This analysis examines the impacts of the Trump administration’s foreign aid freeze on the donor landscape for global health, specifically highlighting the U.S.’s role in supporting global HIV, tuberculosis, and malaria efforts.
Oricell Lands $110M to Take Cell Therapy to New Territory in Cancer
There are no FDA-approved therapies for GPC3, a protein highly expressed by liver cancers. Oricell Therapeutics claims its cell therapy could be best in this class, but it faces competition from companies such as AstraZeneca and Eureka Therapeutics. The post Oricell Lands $110M to Take Cell Therapy to New Territory in Cancer appeared first on…
Patty Hayward, TalkDesk
Patty Hayward is GM of Healthcare and Life Sciences at TalkDesk. TalkDesk runs the technology for contact centers that helps companies across health care connect and manage their consumers. You’ve probably unknowingly used their technology when you call (or now text or email) your health plan, your provider system or call into one of those…
MedCity FemFwd: Inside Build Health International’s New Maternal Center of Excellence in Sierra Leone
In this episode, we’re joined by Allison Adamson, an architect at Build Health International. We discuss Build Health International’s new Maternal Center of Excellence in Sierra Leone. The post MedCity FemFwd: Inside Build Health International’s New Maternal Center of Excellence in Sierra Leone appeared first on MedCity News.
Healthcare Bankruptcies Rise in Q1: 6 Things to Know
A new report from Gibbins Advisors showed that healthcare bankruptcy filings rose 33% in the first quarter of 2026, driven mostly by outpatient and senior care providers. At the same time, hospital M&A activity rebounded to its strongest first quarter since early 2020. The post Healthcare Bankruptcies Rise in Q1: 6 Things to Know appeared…